Transposable element activation promotes neurodegeneration in a Drosophila model of Huntington's disease

Assunta Maria Casale1, Francesco Liguori1, Federico Ansaloni2

  • 1Department of Biology and Biotechnology "C. Darwin", Sapienza University of Rome, Rome, Italy.

Iscience
|January 17, 2022
PubMed

Insights

This study reveals that increased transposable element (TE) activity contributes to neurotoxicity in Huntington's disease (HD) models. Inhibiting TE mobilization offers a promising therapeutic strategy for this genetic disorder.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Huntington's disease (HD) is a fatal neurodegenerative disorder caused by CAG repeat expansion in the Huntingtin gene.
  • Currently, no effective treatments exist for HD, necessitating the identification of novel therapeutic targets.
  • Transposable elements (TEs), or 'jumping genes,' are DNA sequences capable of changing their genomic position and are implicated in neurological diseases.

Purpose of the Study:

  • To investigate the role of TE activity in Huntington's disease pathogenesis.
  • To explore the potential of inhibiting TE mobilization as a therapeutic strategy for HD.

Main Methods:

  • Utilized a *Drosophila melanogaster* model of Huntington's disease.
  • Assessed TE expression and mobilization in the HD model.
  • Administered Reverse Transcriptase inhibitors to block TE mobilization.
  • Evaluated the effects of TE inhibition on neurodegeneration, genome instability, and lifespan.

Main Results:

  • TE expression and mobilization were significantly increased in the *Drosophila* HD model.
  • Inhibition of TE mobilization using Reverse Transcriptase inhibitors rescued polyglutamine-dependent eye neurodegeneration.
  • TE inhibition also reduced genome instability in larval brains and extended fly lifespan.
  • These findings demonstrate a link between TE activation and polyQ-induced neurotoxicity.

Conclusions:

  • TE activation is implicated in the neurotoxicity associated with Huntington's disease.
  • Inhibiting TE mobilization presents a potential novel therapeutic avenue for treating HD.
  • Targeting TE activity could offer a new strategy to combat polyglutamine-induced neurodegeneration.

Related Concept Videos

DNA-only Transposons02:57

DNA-only Transposons

DNA-only transposons are called autonomous transposons since they code for the enzyme transposase that is required for the transposition mechanism. Insertion of transposons can alter gene functions in multiple ways. They can mutate the gene, alter gene expression by introducing a novel promoter or insulator sequence, introduce new splice sites, and change the mRNA transcripts produced, or remodel chromatin structure.
The donor site from where the transposon is excised is either degraded or...
14.9K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.0K
Overview of Transposition and Recombination02:13

Overview of Transposition and Recombination

Transposons make up a significant part of genomes of various organisms. Therefore, it is believed that transposition played a major evolutionary role in speciation by changing genome sizes and modifying gene expression patterns. For example, in bacteria, transposition can lead to conferring antibiotic resistance. Movement of transposable elements within the genetic pool of pathogenic bacteria can aid in transfer of antibiotic-resistant genetic elements. In eukaryotes, transposons can carry out...
16.3K